Wang, Yumeng
Zhang, Shujie
He, Huiqin
Luo, Hongyi
Xia, Yannan
Jiang, Yuanyuan
Jiang, Jingwei http://orcid.org/0000-0002-9163-3633
Funding for this research was provided by:
National Natural Science Foundation of China (no 2018ZX09735001-004, no 81872892)
Article History
Received: 21 December 2022
Revised: 27 January 2023
Accepted: 1 February 2023
First Online: 11 February 2023
Competing interests
: The authors declare no competing interests.
: All listed authors agree to publish the data of this study.
: The tumor sample collection of this study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Medical Ethics Committee of the JIANGSU CANCER HOSPITAL and performed according to institutional guidelines (No. YB M-10-09). The animal experiment of this study was approved by the Ethics Committee of China Pharmaceutical University with the ethics code (2022-05-024).